Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Good Growth Capital is an early-stage venture capital firm founded in 2020, with offices in Charleston, South Carolina, and Boston, Massachusetts. The firm focuses on transformative science and technology, investing primarily in North America. While specific fund size and assets under management are not disclosed, their portfolio reflects a commitment to high-impact sectors.
Good Growth Capital invests in a range of sectors including Life Sciences, Data Sciences, GreenTech, Medical Devices, and Clean Energy. They target pre-seed, seed, and Series A stages, with check sizes typically aligned with early-stage funding. The firm emphasizes investments that align with the UN Sustainable Development Goals and prioritizes diversity among its portfolio companies.
Notable portfolio companies include AdipoPharma, a biotechnology firm developing a therapeutic peptide for diabetes; Aluna, which offers an asthma management platform; and Angiocrine Bioscience, focused on cell therapies for hematologic diseases. Other significant investments include Aoa Diagnostics, Aralez Bio, and Ateios, specializing in solid-state battery technology.
Submit your pitch through their website's contact form for consideration.
Yes, Good Growth Capital often leads investment rounds, particularly in their focus sectors.
The firm is open to follow-on investments, especially for companies that align with their impact and diversity goals.
Specific details about the fund size are not publicly available, but the firm actively builds a diverse portfolio in high-impact sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.